Up- and down-regulation of granulocyte/macrophage-colony stimulating factor activity in murine skin increase susceptibility to skin carcinogenesis by independent mechanisms

Cancer Research

Volumn 61, Issue 5, 2001, Pages 2311-2319

  Mann, Amrit ^a   Breuhahn, Kai ^a,c   Schirmacher, Peter ^b   Wilhelmi, Arnd ^a   Beyer, Carsten ^a   Rosenau, Andrea ^a   Özbek, Suat ^a   Rose John, Stefan ^a,c   Blessing, Manfred ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CANCER; SKIN CARCINOGENESIS; TRANSGENIC MOUSE; TUMOR GROWTH; TUMOR PROMOTION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; DOWN-REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; KERATIN-10; KERATINS; MELANOMA, EXPERIMENTAL; MICE; MICE, TRANSGENIC; NEOPLASM TRANSPLANTATION; PHENOTYPE; SKIN; SKIN NEOPLASMS; SKIN PHYSIOLOGY; TETRADECANOYLPHORBOL ACETATE; TRANSGENES; UP-REGULATION;

EID: 0035266248     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. The granulocyte-macrophage colony-stimulating factors
2. A human GM-CSF receptor expressed in transgenic mice stimulates proliferation and differentiation of hemopoietic progenitors to all lineages in response to human GM-CSF
3. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF α
4. Keratinocyte derived T-cell growth factor (KTGF) is identical to granulocyte macrophage colony stimulating factor (GM-CSF)
5. Granulocyte-macrophage colony-stimulating factor: Pleiotropic cytokine with potential clinical usefulness
6. GM-CSF activates regenerative epidermal growth and stimulates keratinocyte proliferation in human skin in vivo
7. Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation
8. Overexpression of GM-CSF in the epidermis of transgenic mice induces both keratinocyte proliferation and apoptosis
9. Granulocyte-macrophage colony stimulating factor gene expression and function during tumor promotion
10. Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing
11. Granulocyte-macrophage colony-stimulating factor (GM-CSF) is expressed in mouse skin in response to tumor-promoting agents and modulates dermal inflammation and epidermal dark cell numbers
12. Elaboration of granulocyte-macrophage colony-stimulating factor by human tumor cell lines and normal urothelium
13. A correlation between GM-CSF gene expression and metastases in murine tumors
14. Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells
15. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer
16. Autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in human gliomas with tumor progression
17. Antitumor activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumor cell vaccine
18. Targeting head and neck cancer by GM-CSF-mediated gene therapy in vitro
19. Combination immunotherapy of B16 melanoma using anticytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation
20. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting antitumor intmunity
21. Antimetastatic vaccination of tumor-bearing mice with two types of IFN-γ gene-inserted tumor cells
22. Interleukin-6 receptor-interleukin-6 fusion proteins with enhanced interleukin-6 type pleiotropic activities
23. A bioactive designer cytokine for human hematopoietic progenitor cell expansion
24. CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma
25. The central role of CD4(+) T cells in the antitumor immune response
26. Role of bone marrow-derived cells in presenting MHC class 1-restricted tumor antigens
27. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
28. Identification of proliferating dendritic cell precursors in mouse blood
29. Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma
30. Recombinant human granulocyte macrophage-colony stimulating factor (rhGM-CSF) and autologous melanoma vaccine mediate tumor regression in patients with metastatic melanoma
31. Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma
32. Adjuvant therapy of stage Ill and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor
33. Mechanisms of immune suppression in patients with head and neck cancer: Influence on the immune infiltrate of the cancer
34. Paradoxical effect of GM-CSF gene transfer on the tumorigenicity and immunogenicity of murine tumors
35. Multistage carcinogenesis in mouse skin
36. The designer cytokine hyper-IL-6 mediates growth inhibition and GM-CSF-dependent rejection of B16 melanoma cells
37. Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5
38. Rational design of a mouse granulocyte macrophage-colony-stimulating factor receptor antagonist
39. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology
40. Mice deficient for the IL-3/GM-CSF/IL-5 β c receptor exhibit lung pathology and impaired immune response, while β IL3 receptor-deficient mice are normal
41. Rapid and efficient site-specific mutagenesis without phenotypic selection
42. Molecular cloning of cDNA encoding a murine haematopoietic growth regulator, granulocyte-macrophage colony stimulating factor
43. Targeted expression of a dominant-negative FGF receptor mutant in the epidermis of transgenic mice reveals a role of FGF in keratinocyte organization and differentiation
44. Complete sequence of a bovine type 1 cytokeratin gene: Conserved and variable intron positions in genes of polypeptides of the same cytokeratin subfamily
45. Characterization of Al, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2
46. The structure and expression of the murine gene encoding granulocyte-macrophage colony stimulating factor: Evidence for utilisation of alternative promoters
47. Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte
48. FVB/N mice: An inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin
49. Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis
50. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells
51. Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis
52. Identification of an N-terminally truncated form of the chemokine RANTES and granulocyte-macrophage colony-stimulating factor as major eosinophil attractants released by cytokine-stimulated dermal fibroblasts
53. Granulocyte/macrophage colony-stimulating factor is an intrinsic keratinocyte-derived growth factor for human melanocytes in UVA-induced melanosis
54. Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: Inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions
55. Signal transduction by the high-affinity GM-CSF receptor: Two distinct cytoplasmic regions of the common β subunit responsible for different signaling
56. Suppression of apoptotic death in hematopoietic cells by signaling through the IL-3/GM-CSF receptors
57. Increased tolerance to endotoxin by granulocyte-macrophage colony-stimulating factor-deficient mice
58. Regulation of IFN-γ production in granulocyte-macrophage colony-stimulating factor-deficient mice
59. Early inflammatory changes in the skin of SENCAR and C57BL/6 mice following exposure to 12-O-tetradecanoylphorbol-13-acetate
60. Correlation between sensitivity to tumor promotion and sustained epidermal hyperplasia of mice and rats treated with 12-O-tetradecanoylphorbol-13-acetate
61. Transgenic overexpression of transforming growth factor α bypasses the need for c-Ha-ras mutations in mouse skin tumorigenesis
62. Transgenic mice provide new insights into the role of TGF-α during epidermal development and differentiation
63. Epidermal expression of transforming growth factor-α in transgenic mice: Induction of spontaneous and 12-O-tetradecanoylphorbol-13-acetate-induced papillomas via a mechanism independent of Ha-ras activation or overexpression
64. TGF α and v-fos cooperation in transgenic mouse epidermis induces aberrant keratinocyte differentiation and stable, autonomous papillomas
65. Elicitation of a systemic and protective antimelanoma immune response by an IL-2-based vaccine
66. Murine tumor cells transduced with the gene for tumor necrosis factor-α
67. Granulocyte-macrophage colony-stimulating factor (GM-CSF) secreted by cDNA-transfected tumor cells induces a more potent antitumor response than exogenous GM-CSF
68. GM-CSF-induced in vivo expansion of splenic dendritic cells and their strong costimulation activity
69. Dendritic cells and the control of immunity
70. Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4